Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs

Launched by BENI-SUEF UNIVERSITY · Feb 6, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of two types of devices called spacers that help deliver asthma medication (specifically salbutamol) through a metered-dose inhaler (MDI). Researchers want to find out if emergency spacers work better than traditional spacers for delivering the medication in both young children and adults with mild to moderate asthma. The study will measure how much medicine gets into the lungs, how well the lungs function after using the devices, and any potential side effects.

To participate, you must be between 6 and 80 years old and have mild or moderate asthma. Unfortunately, severe asthma patients or those with certain health issues, like heart problems or recent surgeries, are not eligible. If you decide to join the trial, you can expect to inhale the medication using both types of spacers, undergo lung function tests, and provide urine samples after taking the medicine. This study aims to improve asthma treatment for patients by ensuring that they receive the right amount of medication effectively and safely.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Mild and moderate asthmatic patients aged from 6 - 80 year old.
• Exclusion Criteria:
• • Severe asthmatics or patients admitted to an intensive care unit
• • ischemic heart disease
• • recent abdominal surgery
• • inability to perform properly the pulmonary function tests
• • hepatic or renal impairment
• • hypersensitivity to salbutamol.